RethinkFirst Unveils RethinkFutures to Help Payors Drive Improvements in Autism Care Management, Parent Support, and Provider Networks

RethinkFirst, a global behavioral health technology company offering industry leading software and solutions for autism services launched RethinkFutures. This new division delivers clinical data and analytics for payors and health plans to optimize autism care, including solutions for individual care planning, caregiver support, health equity, and provider network management. Led by seasoned healthcare industry experts and clinicians, the division’s solutions help payors accelerate access, improve outcomes and enable value-based care.

Recommended AI News: Pure Storage and Snowflake Deliver Increased Data Accessibility

“Historically, lack of data in autism care has left health plans and payors in the dark, resulting in ineffective or inefficient approaches to care with unpredictable patient outcomes and treatment costs,” said Daniel Etra, RethinkFirst CEO. “We are thrilled to launch RethinkFutures to focus exclusively on supporting payors as they transform how autism care is accessed and delivered. Our leadership team will be pivotal in helping us bring to market a growing portfolio of evidence-based solutions that improve outcomes and shine unprecedented light on every element of the system.”

Applied Behavioral Analysis (ABA) is one of the most widely used therapies for individuals with autism, however, there is currently no standard protocol for prescribing treatment—meaning that individuals might be over- or under-prescribed therapy hours. Under the current fee-for-service (FFS) reimbursement system, research suggests that clinicians are incentivized to request more service hours than the patient may need and maintain those hours despite potentially viable discharge plans.

Recommended AI News: Nasuni Acquires DBM Cloud Systems’ Data Mobility Technology

Due to considerations such as social determinants of health (SDOH) and co-morbidities, one study found that 23% of children with autism never initiate treatment, and of those that do 31% discontinue treatment within one year. Only 15% receive 80% or more of the recommended therapy hours. ABA is not one-size-fits-all; it is a highly individualized therapy. Without appropriate intervention, patients may be at risk of not achieving communication, relationship or social goals.

To improve autism care outcomes, RethinkFutures has developed a patent pending artificial intelligence powered platform that enables practical answers to big challenges. The platform leverages two key elements: The world’s largest published autism services data set with more than 250 million clinical data points of ABA session delivery, patient demographics, and outcomes; and its ABA Clinical Decision Support Platform, which pairs that data with clinical expertise, a patient’s unique profile and modern data science to recommend the optimal dosage of ABA therapy for each individual. The results:

Recommended AI News: Dell Technologies Storage Software Innovations Power New Levels of Automation, Security and Multi-Cloud Flexibility

[To share your insights with us, please write to sghosh@martechseries.com]